跳至主要内容
临床试验/ISRCTN43423520
ISRCTN43423520已完成未知

An international multi-centre long-term follow-up study of the long-term outcomes and impact of cancer treatments in 'triple-negative' breast cancer

niversity of Leeds (UK)0 个研究点目标入组 500 人开始时间: 2014年5月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Participated in the BEATRICE trial
  • 2. Aged 18 or over
  • 3. Currently being followed up at a site participating in the LOTUS study
  • 4. Able to provide informed consent and comply with the trial schedule

排除标准

  • 1. Withdrawn from follow up from the BEATRICE trial
  • 2. Given adjuvant endocrine therapy after completion of adjuvant chemotherapy

研究者

发起方
niversity of Leeds (UK)

相似试验